strawberries
Dietary SupplementFreeze-dried strawberry powder
NCT Number: NCT03441620
In this study, we propose to investigate the effects of dietary achievable doses of strawberries on serum LDL-cholesterol (LDL-C) and related lipid profiles, measures of glycemia and insulin resistance, and biomarkers of inflammation in a 14 week controlled crossover study.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
University of Nevada at Las Vegas, Las Vegas, Nevada, United States
The screen visit will involve an 8 hour fasting state and the following procedures:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Freeze-dried strawberry powder
Control powder matched for fiber and strawberries
Time frame: 14 weeks
Serum LDL, total and HDL cholesterol, triglycerides
Time frame: 14 weeks
Blood glucose
Time frame: 14 weeks
Molar concentrations of serum lipids and particle size
Time frame: 14 weeks
Insulin resistance
Time frame: 14 weeks
Serum C-reactive protein and adipokines
Time frame: 14 weeks
Strawberry anthocyanin metabolites measured in serum
Time frame: 14 weeks
primary and lipid metabolites in serum
University of Nevada, Las Vegas
Other
Effects of Strawberries on LDL Cholesterol and Insulin Resistance in Overweight/Obese Adults With the Metabolic Syndrome.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05956886
Dyssomnias, Glucose Metabolism Disorders
Newark, Delaware, United States
View Trial DetailsNCT07739602
Glucose Metabolism Disorders, Hyperinsulinism
Wroclaw, Poland
View Trial DetailsNCT04057339
Behavior, Fasting
La Jolla, California, United States
View Trial DetailsNCT07702669
Glucose Metabolism Disorders, Hyperinsulinism
Harbin, Heilongjiang, China
View Trial Details